Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Elisa Macrì"'
Autor:
Elisa Sturabotti, Silvia Consalvi, Luca Tucciarone, Elisa Macrì, Valerio Di Lisio, Iolanda Francolini, Carmen Minichiello, Antonella Piozzi, Claudia Vuotto, Andrea Martinelli
Publikováno v:
Gels, Vol 8, Iss 8, p 480 (2022)
Here, we present a one-pot procedure for the preparation of hyaluronic acid (HA) sulfonated hydrogels in aqueous alkaline medium. The HA hydrogels were crosslinked using 1,4-butanedioldiglycidyl ether (BDDE) alone, or together with N-bis(2-hydroxyeth
Externí odkaz:
https://doaj.org/article/17bcedbd315b4019ad7a5662f4cc665c
Autor:
Botta, Virginia Veronica Visconti, Elisa Macrì, Maria Rosaria D’Apice, Federica Centofanti, Roberto Massa, Giuseppe Novelli, Annalisa
Publikováno v:
International Journal of Molecular Sciences; Volume 24; Issue 12; Pages: 10129
Myotonic dystrophy type 1 (DM1) is an autosomal dominant multisystemic disease caused by a CTG repeat expansion in the 3′-untranslated region (UTR) of DMPK gene. DM1 alleles containing non-CTG variant repeats (VRs) have been described, with uncerta
Autor:
Silvia Consalvi, Luca Tucciarone, Elisa Macrì, Marco De Bardi, Mario Picozza, Illari Salvatori, Alessandra Renzini, Sergio Valente, Antonello Mai, Viviana Moresi, Pier Lorenzo Puri
Publikováno v:
EMBO reports. 23
Pharmacological treatment of Duchenne muscular dystrophy (DMD) with histone deacetylase inhibitors (HDACi) is currently being tested in clinical trials; however, pre-clinical studies indicated that the beneficial effects of HDACi are restricted to ea
Autor:
Federica Centofanti, Virginia Veronica Visconti, Simona Fittipaldi, Elisa Macrì, Annalisa Botta, Giuseppe Novelli
Publikováno v:
International Journal of Molecular Sciences
International Journal of Molecular Sciences, Vol 22, Iss 12594, p 12594 (2021)
International Journal of Molecular Sciences, Vol 22, Iss 12594, p 12594 (2021)
Myotonic dystrophy type 1 and 2 (DM1 and DM2) are two multisystemic autosomal dominant disorders with clinical and genetic similarities. The prevailing paradigm for DMs is that they are mediated by an in trans toxic RNA mechanism, triggered by untran